CJC-1295 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-08 and is reviewed periodically as new material appears.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
=== Risk of death === A 2017 meta-analysis found that antidepressants, including SSRIs, were associated with significantly increased risk of death (+33%) and new cardiovascular complications (+14%) in the general population. Conversely, risks were not greater in people with existing cardiovascular disease.
=== South Africa === Saudi Arabia supplies most of South Africa's fuel. The South African Government has said that there was no shortage of fuel in the country, but prices have increased and some petrol stations have introduced their own rationing of diesel. With more traffic potentially taking the route around the Cape of Good Hope, and ships needing to fuel along the African coast, some ports such as Walvis Bay, Cape Town, and Durban may come under increased pressure, but also benefit from the diversion.
== Medical uses == Medications based on incretins are used in the treatment of type 2 diabetes mellitus as well as the management of obesity. Most of the earliest incretin-targeting agents to be approved fell into the class of DPP-4 inhibitors; these inhibit DPP-4 and prevent the enzymatic degradation of GLP-1 and GIP. The first medication in this class, sitagliptin, received FDA approval in 2006 for the treatment of type 2 diabetes. GLP-1 analogs principally act as agonists of the GLP-1 receptor and are thus insulinotropic. Exenatide was the first drug in this class to be used in the treatment of type 2 diabetes; it received FDA approval in 2005. More recently, longer-acting and more potent GLP-1 analogs have been developed, most notably semaglutide, which received FDA approval for type 2 diabetes in 2017. It was subsequently approved for the management of obesity. In 2021, it was in the Top 100 most-prescribed drugs in the United States. Tirzepatide (sold as Mounjaro and Zepbound) is a potent GIP analog with agonist activity at GIP and GLP-1 receptors. It was approved for the treatment of type 2 diabetes in the United States in May 2022, and for the management of obesity in November 2023.
FS−SF → S=SF2 Decomposing to sulfur tetrafluoride and sulfur when heated to 180 °C: 2 S2F2 → SF4 + 3 S Hydrolysis: 2 S2F2 + 2 H2O → SO2 + 3 S + 4 HF Reacting with sulfuric acid at 80 °C: S2F2 + 3 H2SO4 → 5 SO2 + 2 HF + 2 H2O Reacting with sodium hydroxide: 2 S2F2 + 6 NaOH → Na2SO3 + 3 S + 4 NaF + 3 H2O Reacting with oxygen at high pressure, using nitrogen dioxide as a catalyst: 2 S2F2 + 5 O2 → SOF4 + 3 SO3
== Biosynthesis == NAAG synthetase activity mediates the biosynthesis of NAAG from glutamate and NAA, but little is known about the mechanism or regulation of this enzyme, and no NAAG synthetase activity has been isolated in cell-free preparations. Since other neuropeptides and nearly all vertebrate peptides are synthesized by post-translational processing, NAAG synthetase activity is relatively unique. As with NAA, the synthesis of NAAG is primarily restricted to neurons, although glial cells also contain and synthesize this peptide. In vitro, NAAG synthesis appears to be regulated by the availability of its precursor, NAA. In addition, during differentiation of neuroblastoma cells, it has been shown that a protein kinase A (PKA) activator will increase the quantity of NAAG, while a protein kinase C (PKC) activator will decrease its concentration. This finding suggests that PKA and PKC have opposing regulatory effects on the NAAG synthetase enzyme.
Sources: en.wikipedia.org
In contrast to early inefficient dry- packing methods, wet slurry packing, in which particles that are suspended in an appropriate solvent are delivered into a column under pressure, shows significant improvement. Three different approaches can be employed in performing wet slurry packing: the balanced density method (solvent's density is about that of porous silica particles), the high viscosity method (a solvent of high viscosity is used), and the low viscosity slurry method (performed with low viscosity solvents). Polystyrene is used as a medium for ion-exchange. It is made from the polymerization of styrene with the use of divinylbenzene and benzoyl peroxide. Such exchangers form hydrophobic interactions with proteins which can be irreversible. Due to this property, polystyrene ion exchangers are not suitable for protein separation. They are used on the other hand for the separation of small molecules in amino acid separation and removal of salt from water. Polystyrene ion exchangers with large pores can be used for the separation of protein but must be coated with a hydrophilic substance. Cellulose based medium can be used for the separation of large molecules because they contain large pores. Protein binding in this medium is high and has low hydrophobic character. DEAE is an anion exchange matrix that is produced from a positive side group of diethylaminoethyl bound to cellulose or Sephadex. Agarose gel based medium contain large pores as well but their substitution ability is lower in comparison to dextrans.
=== Amélie of Leuchtenberg === Amélie of Leuchtenberg (1812–1873) was Empress of Brazil as the wife of Emperor Pedro I (also King Pedro IV of Portugal). Between February and September 2012, researchers from the University of São Paulo exhumed her remains, along with those of Pedro I and his first wife, Maria Leopoldina. The investigation revealed that Amélie's body had been mummified, with her skin, hair, and internal organs preserved. Forensic examinations at the Hospital das Clínicas identified an incision in the jugular vein, used to inject aromatic substances such as camphor and myrrh during the original embalming. According to forensic archaeologist Valdirene Ambiel, the preservation was aided by the casket's hermetic seal, which prevented the growth of microorganisms. Before reinterment, the body was re-embalmed using methods similar to the original 19th-century process. The remains of Amélie, Pedro I, and Maria Leopoldina are interred within the crypt of the Monument to the Independence of Brazil in São Paulo.
The science of collecting and analyzing biologic or health data using statistical methods. Biostatistics may be used to help learn the possible causes of a disease in a certain group of people. Also called biometry and biometrics. (NCI) Blind
== SW == sw – (s) Swahili language (ISO 639-1 code) SW (s) South-West ordinal direction Sweden (FIPS 10-4 country code) (a) Shortwave Star Wars swa – (s) Swahili language (ISO 639-2 code) SWA (i/a) Secure Web Access South-West Asia SWAC – (p) Southwestern Athletic Conference SWAG Scientific wild-ass guess, slang for a rough estimate based on expert experience Sourceware Archive Group, a free collection of classified source code and sample programs written in Pascal Sport Writers Association of Ghana, Sports Writers Association based in Ghana Special Warfare Group, a former name used by the Naval Special Operations Command "Supporters Without A Game", sport slang spun off from WAGs ("wives and girlfriends") SWALK – (a) Sealed With A Loving Kiss SWAN – (a) System for Wearable Audio Navigation SWAP – (a) Surface Waters Acidification Programme SWAPO – (a) South-West Africa People's Organisation SWAT – (a) Special Weapons And Tactics swe – (s) Swedish language (ISO 639-2 code) SWE – (s) Sweden (ISO 3166 trigram) SWF (p) Shockwave Flash file ("swiff") Single White Female SWG (i) Surface Warfare Group Symbology Working Group SWHR – (i) Society for Women's Health Research SWIG – (a) Simplified Wrapper and Interface Generator SWIR – (a/i) Short Wave InfraRed ("ss-why-are" or "swhirr") SWLABR – (i) "She Was Like A Bearded Rainbow", a song by the band Cream SWORD – (p) Subjective WORkload Dominance SWORDS – (a) Special Weapons Observation Reconnaissance Detection System SWOT – (a) Strengths, Weaknesses, Opportunities, Threats (mnemonic) SWP (i) Special Working Party ("swipp") Systematic Westing Plan (a plan of periodic westing of shares or mutual funds worth a fixed amount of money) Skill with prize (UK pub quiz machines — quality titles include: Pub Quiz, Quiz City, Frog in a Liquidizer, Who Wants To Win a Tenner?) SWT – (i) Sea Water Tank SWV – (i) Sisters With Voices (American female R&B vocal group) SWZ – (s) Swaziland (ISO 3166 trigram)
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.